BrainCheck Announces 2025 Award Winners, Honoring Leaders Advancing the Future of Cognitive Care
BrainCheck, the leading digital cognitive assessment and care platform, today announced the winners of its inaugural 2025 BrainCheck Awards, honoring the healthcare professionals, researchers, and organizations setting new standards in cognitive care nationwide.
BrainCheck Opens New York City Office to Support Northeast Growth
BrainCheck, a leading digital cognitive assessment and care platform, today announced the opening of its new East Coast office at 325 Hudson Street in New York City.
BrainCheck Awarded $500K NIH SBIR Phase I Grant to Advance eConsult Platform for Cognitive Care
BrainCheck, the leading FDA Class II digital cognitive assessment and care platform, has been awarded a $500,000 SBIR Phase I grant (R43AG094410) from the National Institutes of Health (NIH) to develop and evaluate BrainCheck eConsult, an innovative web-based platform that connects primary care providers (PCPs) with dementia specialists to improve the diagnosis and management of cognitive impairment.
BrainCheck Expands Normative Database to Further Support Accuracy and Consistency in Cognitive Assessment
BrainCheck, a digital cognitive assessment and care platform that includes an FDA Class II medical device (BrainCheck Assess™), today announced the completion of a three-year project expanding its Normative Database — the scientific reference set that supports interpretation of BrainCheck cognitive test results.
BrainCheck Appoints Two New Leaders to Executive Team
BrainCheck, creator of the comprehensive cognitive assessment and care management platform for physicians, today announces the appointment of Trey Swain as Chief Financial Officer and Matthew Cerullo as Chief Revenue Officer to its executive leadership. The announcement follows BrainCheck’s $10 million Series B funding round in November 2021 and highlights its commitment to world-class executive management and long-term strategic growth.
BrainCheck Raises $10 Million in Series B Funding to Transform Cognitive Health Assessment and Care for Alzheimer’s and Related Dementias
BrainCheck, the cognitive healthcare platform for physicians, today announced $10 million in Series B funding. The round is led by Next Coast Ventures and S3 Ventures, with additional investors including Nueterra Capital, Tensility Ventures, and True Wealth Ventures. In addition, UPMC Enterprises and SelectQuote (
NYSE: SLQT) have joined as strategic investors. The round takes the total capital raised by BrainCheck to date to $20 million.
